Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
- PMID: 32157757
- DOI: 10.1111/neup.12644
Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Abstract
Neuronal inclusion of transactivation response DNA-binding protein 43 kDa (TDP-43) is known to be a pathologic hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). TDP-43, which is physiologically a nuclear protein, is mislocalized from the nucleus and aggregated within the cytoplasm of affected neurons in ALS and FTLD patients. Neuropathologic or experimental studies have addressed mechanisms underlying spreading of TDP-43 inclusions in the central nervous system of ALS and FTLD patients. On the basis of postmortem observations, it is hypothesized that TDP-43 inclusions spread along the neural projections. A centrifugal gradient of TDP-43 pathology in certain anatomical systems and axonal or synaptic aggregation of TDP-43 may support the hypothesis. Experimental studies have revealed cell-to-cell propagation of aggregated or truncated TDP-43, which indicates a direct transmission of TDP-43 inclusions to contiguous cells. However, discrepancies remain between the cell-to-cell propagation suggested in the experimental models and the anatomical spreading of TDP-43 aggregations based on postmortem observations. Trans-synaptic transmission, rather than the direct cell-to-cell transmission, may be consistent with the anatomical spreading of TDP-43 aggregations, but cellular mechanisms of trans-synaptic transmission of aggregated proteins remain to be elucidated. Moreover, the spreading of TDP-43 inclusions varies among patients and genetic backgrounds, which indicates host-dependent factors for spreading of TDP-43 aggregations. Perturbation of cellular TDP-43 clearance may be a possible factor modifying the aggregation and spreading. This review discusses postmortem and experimental evidence that address mechanisms of spreading of TDP-43 pathology in the central nervous system of ALS and FTLD patients.
Keywords: ALS; FTLD; TDP-43; neural projections; propagation.
© 2020 Japanese Society of Neuropathology.
Similar articles
-
Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.Int J Mol Sci. 2021 Apr 8;22(8):3843. doi: 10.3390/ijms22083843. Int J Mol Sci. 2021. PMID: 33917673 Free PMC article. Review.
-
Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.Acta Neuropathol Commun. 2017 Oct 27;5(1):76. doi: 10.1186/s40478-017-0480-2. Acta Neuropathol Commun. 2017. PMID: 29078806 Free PMC article.
-
TDP-43 mutants with different aggregation properties exhibit distinct toxicity, axonal transport, and secretion for disease progression in a mouse ALS/FTLD model.Neurobiol Dis. 2025 Aug;212:106988. doi: 10.1016/j.nbd.2025.106988. Epub 2025 Jun 5. Neurobiol Dis. 2025. PMID: 40482730
-
Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.Neuropathology. 2018 Feb;38(1):72-81. doi: 10.1111/neup.12428. Epub 2017 Sep 27. Neuropathology. 2018. PMID: 28960544 Review.
-
Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions.Acta Neuropathol Commun. 2020 Oct 28;8(1):176. doi: 10.1186/s40478-020-01055-9. Acta Neuropathol Commun. 2020. PMID: 33115537 Free PMC article.
Cited by
-
Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.Int J Mol Sci. 2021 Apr 8;22(8):3843. doi: 10.3390/ijms22083843. Int J Mol Sci. 2021. PMID: 33917673 Free PMC article. Review.
-
Modeling seeding and neuroanatomic spread of pathology in amyotrophic lateral sclerosis.Neuroimage. 2022 May 1;251:118968. doi: 10.1016/j.neuroimage.2022.118968. Epub 2022 Feb 7. Neuroimage. 2022. PMID: 35143975 Free PMC article.
-
TDP-43 differentially propagates to induce antero- and retrograde degeneration in the corticospinal circuits in mouse focal ALS models.Acta Neuropathol. 2023 Oct;146(4):611-629. doi: 10.1007/s00401-023-02615-8. Epub 2023 Aug 9. Acta Neuropathol. 2023. PMID: 37555859
-
Molecular, functional, and pathological aspects of TDP-43 fragmentation.iScience. 2021 Apr 21;24(5):102459. doi: 10.1016/j.isci.2021.102459. eCollection 2021 May 21. iScience. 2021. PMID: 34013172 Free PMC article. Review.
-
The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.Brain Imaging Behav. 2021 Oct;15(5):2693-2719. doi: 10.1007/s11682-020-00429-w. Epub 2021 Jan 5. Brain Imaging Behav. 2021. PMID: 33398779
References
REFERENCES
-
- Buratti E, Dörk T, Zuccato E, Pagani F, Romano M, Baralle FE. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 2001; 20: 1774-1784.
-
- Neumann M, Sampathu DM, Kwong LK et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
-
- Arai T, Hasegawa M, Akiyama H et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
-
- Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K. Amyotrophic lateral sclerosis-a model of corticofugal axonal spread. Nat Rev Neurol 2013; 9: 708-714.
-
- Brettschneider J, Del Tredici K, Irwin DJ et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 2014; 127: 423-439.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous